Alexandria Real Estate Equities (ARE)
(Delayed Data from NYSE)
$116.24 USD
-0.87 (-0.74%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $116.23 -0.01 (-0.01%) 7:14 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$116.24 USD
-0.87 (-0.74%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $116.23 -0.01 (-0.01%) 7:14 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Zacks News
Is it Wise to Retain Ventas (VTR) Stock in Your Portfolio?
by Zacks Equity Research
A favorable demand in senior housing, backed by an expected rise in senior citizens' population is likely to support Ventas (VTR). However, dependence on a few tenants and high interest rates are woes.
Should Investors Retain Healthpeak (DOC) Stock for Now?
by Zacks Equity Research
Solid demand for lab assets and rising healthcare expenditure by senior citizens bode well for Healthpeak (DOC). However, competition from peers and high interest rates are woes.
Here's Why Alexandria (ARE) Is an Apt Portfolio Pick for Now
by Zacks Equity Research
Robust demand for Alexandria's (ARE) high-quality life science and lab office properties in key markets, healthy operating performance and expansion efforts bode well for long-term growth.
Alexandria Real Estate Equities (ARE) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
3 Top Dividend Stocks to Maximize Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Alexandria (ARE) Sees Demand, Seals Early Renewal With insitro
by Zacks Equity Research
Alexandria's (ARE) securing of an early renewal with insitro for a six-year lease extension at the Alexandria Center for Advanced Technologies highlights the solid demand for its mega campus.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Why Alexandria Real Estate Equities (ARE) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Alexandria (ARE) Announces Lease Extension at Kendall Square
by Zacks Equity Research
Alexandria's (ARE) securing of renewal and lease extension with Takeda at Kendall Square in Cambridge highlights solid demand for its mega campus.
Why Alexandria Real Estate Equities (ARE) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
Ventas' (VTR) Q4 FFO Meets Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Ventas' (VTR) Q4 results outshine estimates on better-than-anticipated revenues. The same-store NOI improves across the portfolio. It has also issued its 2024 outlook.
Welltower (WELL) Q4 FFO Beat Estimates, SHO Occupancy Rises
by Zacks Equity Research
Welltower's (WELL) Q4 earnings outshine estimates on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year.
Healthpeak's (PEAK) Q4 FFO Beat Estimates, Same-Store NOI Up
by Zacks Equity Research
Healthpeak's (PEAK) Q4 results outshine estimates on better-than-anticipated revenues. Same-store cash NOI for the total portfolio improves year over year. It has issued its 2024 outlook.
Cousins Properties (CUZ) Q4 FFO Meets Mark, '24 View Issued
by Zacks Equity Research
Cousins Properties' (CUZ) Q4 FFO per share meets expectations. The top line improves year over year. It has issued its 2024 outlook for FFO per share.
Alexandria Real Estate Equities (ARE) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Alexandria Real Estate Equities (ARE) have what it takes? Let's find out.
Rayonier (RYN) Q4 Earnings Meet Estimates, Revenues Lag
by Zacks Equity Research
Rayonier's (RYN) Q4 earnings meet estimates despite lower-than-anticipated revenues. The pro forma operating income declines in most segments excluding Real Estate. It has issued its 2024 outlook.
Boston Properties (BXP) Q4 FFO & Revenues Top, '24 View Issued
by Zacks Equity Research
Boston Properties' (BXP) Q4 results outshine estimates on better-than-anticipated revenues, aided by solid leasing activity. It issues its guidance for 2024 FFO per share.
Alexandria's (ARE) Q4 AFFO Misses Estimates, '24 View Issued
by Zacks Equity Research
Alexandria's (ARE) Q4 results reflect lower-than-anticipated AFFO per share despite a rise in revenues. It has also issued its 2024 outlook.
Alexandria Real Estate Equities (ARE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Alexandria Real Estate Equities (ARE) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
SL Green's (SLG) Q4 FFO Lag Estimates, 2024 View Raised
by Zacks Equity Research
SL Green's (SLG) Q4 FFO misses estimates on lower-than-anticipated revenues. However, same-store cash net operating income improves year over year.